Souvenaid Powder Chocolate Hazelnut Flavour 360 g

Original price was: $54.00.Current price is: $38.98. 28% off RRP

Out of stock SKU: 13259

Want to be notified when this product is back in stock?

Souvenaid Powder is a nutritional drink available in a tin with 3 delicious flavours: Vanilla & Banana and Lemon & Orange and NEW flavour Chocolate. Designed to be taken once daily. One tin contains 12 daily serves. Souvenaid is powered by Fortasyn Connect, a unique blend of ingredients to support the growth of brain connections.

Product Benefits:

  • Omega-3 fatty acids
  • Uridine monophosphate
  • Choline
  • Phospholipids, B vitamins and antioxidants

360 g

Souvenaid Powder – Chocolate Hazelnut Flavour

Directions

Recommended intake of 1 serve per day

Step 1: Add 3 scoops of powder to a glass
Step 2: Add 100ml of water to the powder. Mix well until dissolved
Step 3: Consume entire serve immediately after preparation

Ingredients

Dried omega long chain polyunsaturated fatty acids (tuna fish oil), glucose syrup, sodium caseinate (milk), antioxidants (sodium ascorbate, mixed tocopherols, ascorbyl palmitate), whey protein (milk), dipotassium phosphate, emulsifier (471), anti-caking agent (551), skim milk powder, sugar, maltodextrin, cocoa powder, choline bitartrate, uridine 5′ monophospate, flavours (Chocolate and hazelnut (soy), soy lecithin.

Minerals: Potassium, soidum phosphorus, magnesium, iron, zinc, manganese, copper, selenium, iodine, chromium, molybdenium

Vitamins: Vitamins (A, B1, B2, B3, B5, B6, B12, C, D3, E, K) folic acid, biotin

Contains: milk, fish, soy

Warnings

For oral consumption only.
Must be used under medical supervision.
Not suitable as a sole source of nutrition.
Only to be used in addition to the normal diet.

Weight 0.45 kg
Dimensions 20 × 20 × 20 cm
Barcode

Souvenaid

With over 20 years of evidence based research, Souvenaid® has been shown to support memory function when initiated in the early stages of Alzheimer's disease. An independent study funded by the European Commission, investigated the long term use and impact of Souvenaid on memory and cognitive function in the very early stages of Alzheimer’s disease, including mild cognitive impairment.